CMS proposes to hold drugmakers and PBMs accountable for cost of drugs covered by Medicaid

The Centers for Medicare and Medicaid Services has issued a proposed rule to drive down prescription drug costs in Medicaid by increasing price transparency.  The rule would allow CMS to have more insight into what the most expensive drugs on the market actually cost to manufacture and distribute.  

Read the full post at News Feed
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive